Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lu AF28996 single- and sequential-ascending-dose pharmacokinetic study in healthy young men
NL-OMON48715Active, not recruiting
- Sponsor
- QPS
- Start
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of Lu AF28996 in Parkinson's disease (PD), sponsored by QPS. Primary endpoint: Pharmacokinetics of Lu AF28996. Started Jun 2018; status: active, not recruiting.
02
Drugs
Lu AF28996
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NL-OMON48715.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON48715.